Published in HPB (Oxford) on August 19, 2011
The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations. J Clin Exp Hepatol (2014) 1.12
Hepatocellular carcinoma--resection or transplant? Nat Rev Gastroenterol Hepatol (2012) 0.92
Liver Transplantation for HCC: A Review. Indian J Surg (2011) 0.82
The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma. World J Surg (2015) 0.79
Resection for hepatocellular carcinoma. J Clin Exp Hepatol (2014) 0.79
The Warsaw Proposal for the Use of Extended Selection Criteria in Liver Transplantation for Hepatocellular Cancer. Ann Surg Oncol (2016) 0.77
Is liver transplantation using organs donated after cardiac death cost-effective or does it decrease waitlist death by increasing recipient death? HPB (Oxford) (2012) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA (1996) 14.23
How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ (1992) 10.40
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol (2009) 9.84
Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med (1977) 8.60
Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA (1996) 8.52
The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA (1996) 6.80
Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol (2005) 6.22
Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology (1999) 5.70
Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis (2005) 4.51
Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making (1985) 4.47
Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology (2003) 4.13
Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology (2010) 3.98
Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg (1993) 3.91
Complications of radiofrequency coagulation of liver tumours. Br J Surg (2002) 3.39
A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology (2005) 3.26
Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg (1991) 3.12
Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology (2008) 2.59
The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg (2009) 2.51
Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl (2002) 2.28
Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology (2010) 2.08
Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg (2003) 2.02
Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg (2004) 1.99
Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl (2006) 1.72
Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl (2004) 1.58
Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma. Liver Transpl (2002) 1.57
Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation. Health Technol Assess (2006) 1.50
Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. Am J Med (1996) 1.44
Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population. Am J Surg (2008) 1.43
Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut (2002) 1.29
Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg (2004) 1.25
Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective. Hepatology (1998) 1.24
Treatment before liver transplantation for HCC. Ann Surg Oncol (2008) 1.22
Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol (2010) 1.21
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health Technol Assess (2007) 1.21
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. Am J Transplant (2010) 1.18
Preferences for health outcomes and cost-utility analysis. Am J Manag Care (1997) 1.15
Waiting list removal rates among patients with chronic and malignant liver diseases. Am J Transplant (2006) 1.12
Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg (2006) 1.11
Survival and cost-effectiveness analysis of competing strategies in the management of small hepatocellular carcinoma. Liver Transpl (2010) 1.08
Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol (2008) 1.06
Cost effectiveness of combination therapy for hepatitis C: a decision analytic model. Gut (2002) 1.03
Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma. Mol Cancer (2010) 1.01
Hepatic resection versus radiofrequency ablation for hepatocellular carcinoma in cirrhotic individuals not candidates for liver transplantation: a Markov model decision analysis. Am J Surg (2009) 0.99
Decision analysis and economic modelling: a primer. Eur J Gastroenterol Hepatol (2004) 0.97
Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol (2005) 0.91
Radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. HPB (Oxford) (2010) 0.90
Decision analysis models: opening the black box. Surgery (2003) 0.85
Management of the single liver nodule in a cirrhotic patient: a decision analysis model. J Clin Gastroenterol (2005) 0.80
Molecular signature of early hepatocellular carcinoma. Oncology (2010) 0.77
Long-term survival after resection for primary hepatic carcinoid tumor. Ann Surg Oncol (2003) 3.18
Diagnosis and treatment of cholangiocarcinoma. Oncologist (2004) 2.00
Effective treatment of biliary cystadenoma. Ann Surg (2005) 1.83
Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg (2004) 1.77
Psychometric characteristics of a condition-specific, health-related quality-of-life survey: the FACT-Vanderbilt Cystectomy Index. Urology (2012) 1.56
The impact of aviation-based teamwork training on the attitudes of health-care professionals. J Am Coll Surg (2004) 1.55
The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery (2008) 1.55
Use of short tandem repeats for DNA fingerprinting to rapidly diagnose graft-versus-host disease in solid organ transplant patients. Transplantation (2006) 1.54
Pre-transplant overweight and obesity do not affect physical quality of life after kidney transplantation. J Am Coll Surg (2010) 1.51
Long-term detrimental effect of bile duct injury on health-related quality of life. Arch Surg (2004) 1.49
Decreased dopamine type 2 receptor availability after bariatric surgery: preliminary findings. Brain Res (2010) 1.41
Can donors with high donor risk indices be used cost-effectively in liver transplantation in US Transplant Centers? Transpl Int (2013) 1.37
The long-term effect of bile duct injuries on health-related quality of life: a meta-analysis. HPB (Oxford) (2012) 1.30
Creating an emergency general surgery service enhances the productivity of trauma surgeons, general surgeons and the hospital. J Trauma (2005) 1.23
Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy. Diabetes Care (2011) 1.21
Teachers' screening for attention deficit/hyperactivity disorder: comparing multinational samples on teacher ratings of ADHD. J Abnorm Child Psychol (2003) 1.20
Implementation of a real-time compliance dashboard to help reduce SICU ventilator-associated pneumonia with the ventilator bundle. Arch Surg (2009) 1.19
Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity. Diabetes Care (2012) 1.14
The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma. Am Surg (2003) 1.12
Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality? Arch Surg (2007) 1.12
Liver and intestine transplantation: summary analysis, 1994-2003. Am J Transplant (2005) 1.09
Recurrent lupus nephritis in renal transplant recipients revisited: it is not rare. Transplantation (2003) 1.07
Management of hepatocellular carcinoma. J Gastrointest Surg (2006) 1.07
Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment. J Hepatobiliary Pancreat Surg (2004) 1.07
Surgical management of polycystic liver disease. World J Gastroenterol (2007) 1.06
Physiologic properties of small intestine submucosa. J Surg Res (2005) 1.04
Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation. Arch Surg (2005) 0.99
Survival after pediatric liver transplantation: why does living donation offer an advantage? Arch Surg (2005) 0.98
CT-based attenuation correction versus prone imaging to decrease equivocal interpretations of rest/stress Tc-99m tetrofosmin SPECT MPI. J Nucl Cardiol (2007) 0.97
A cost-effectiveness analysis of early vs late reconstruction of iatrogenic bile duct injuries. J Am Coll Surg (2012) 0.94
Liver transplantation for non-hepatocellular carcinoma malignancy. HPB (Oxford) (2007) 0.93
Cervical spine evaluation in urban trauma centers: lowering institutional costs and complications through helical CT scan. J Am Coll Surg (2005) 0.92
Liver transplantation for iatrogenic porta hepatis transection. Am Surg (2009) 0.91
The impact of tumor extent (T stage) and lymph node involvement (N stage) on survival after surgical resection for gallbladder adenocarcinoma. HPB (Oxford) (2008) 0.91
Roux-en-Y gastric bypass reverses renal glomerular but not tubular abnormalities in excessively obese diabetics. Surgery (2009) 0.89
Are adrenal injuries predictive of adrenal insufficiency in patients sustaining blunt trauma? Am Surg (2008) 0.89
Is there racial disparity in outcomes after solid organ transplantation? Am J Surg (2004) 0.89
Risk factors for post-operative mortality in bariatric surgery. J Surg Res (2005) 0.89
Reversed activity of mitochondrial adenine nucleotide translocator in ischemia-reperfusion. Transplantation (2003) 0.89
The effects of physical quality of life, time, and gender on change in symptoms of anxiety and depression after liver transplantation. J Gastrointest Surg (2007) 0.89
Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database. J Pediatr Surg (2006) 0.88
A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by positron emission tomography with [18F]fluoro-2-deoxy-D-glucose: role of primary tumor variables. J Am Coll Surg (2008) 0.88
Correlation of health-related quality of life after liver transplant with the Model for End-Stage Liver Disease score. Arch Surg (2009) 0.88
Early weight regain after gastric bypass does not affect insulin sensitivity but is associated with elevated ghrelin. Obesity (Silver Spring) (2014) 0.88
Reduction in corticosteroids is associated with better health-related quality of life after liver transplantation. J Am Coll Surg (2011) 0.87
Health insurance status affects staging and influences treatment strategies in patients with hepatocellular carcinoma. Ann Surg Oncol (2010) 0.87
Novel role of phospholipase C-delta1: regulation of liver mitochondrial Ca2+ uptake. Am J Physiol Gastrointest Liver Physiol (2004) 0.85
Donor conversion and organ yield in traumatic brain injury patients: missed opportunities and missed organs. J Trauma (2008) 0.85
11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma. J Nucl Med (2003) 0.84
Effects of hepatitis C virus infection and its recurrence after liver transplantation on functional performance and health-related quality of life. J Gastrointest Surg (2002) 0.84
Evaluation of living kidney donors: variables that affect donation. Prog Transplant (2012) 0.84
Mitochondrial P2Y-Like receptors link cytosolic adenosine nucleotides to mitochondrial calcium uptake. J Cell Biochem (2004) 0.84
Biliary reconstruction is enhanced with a collagen-polyethylene glycol sealant. Am Surg (2002) 0.84
Endoleak following endovascular abdominal aortic aneurysm repair: implications for duration of screening. Ann Surg (2004) 0.83
Survival and functional quality of life after resection for hepatic carcinoid metastasis. J Gastrointest Surg (2004) 0.83
Ciliated hepatic foregut cysts in children. Pediatr Surg Int (2009) 0.83
Modeling the effects of functional performance and post-transplant comorbidities on health-related quality of life after heart transplantation. J Heart Lung Transplant (2003) 0.83
A clinical comparative analysis of crush/clamp, stapler, and dissecting sealer hepatic transection methods. HPB (Oxford) (2008) 0.82
The Vanderbilt EvidenceWeb - developing tools to monitor and improve compliance with evidence-based order sets. AMIA Annu Symp Proc (2006) 0.82
Incorporating quality of life and patient satisfaction measures into a transplant outcomes assessment program: technical and practical considerations. Prog Transplant (2007) 0.82
Mechanical circulatory support and heart transplantation: donor and recipient factors influencing graft survival. Ann Thorac Surg (2013) 0.82
More donors or more delayed graft function? A cost-effectiveness analysis of DCD kidney transplantation. Clin Transplant (2013) 0.81
Continuous versus interrupted suture for end-to-end biliary anastomosis during liver transplantation gives equal results. Liver Transpl (2007) 0.81
Mitochondrial calcium uptake regulates cold preservation-induced Bax translocation and early reperfusion apoptosis. Am J Transplant (2004) 0.81
Race disparities in firearm injuries and outcomes among Tennessee children. J Pediatr Surg (2012) 0.81
The negative effect of pretransplant overweight and obesity on the rate of improvement in physical quality of life after liver transplantation. Surgery (2009) 0.80
Screening asymptomatic diabetic patients for coronary artery disease prior to renal transplantation. Transplantation (2005) 0.80
Validation of the Written Administration of the Short Literacy Survey. J Health Commun (2015) 0.79
Improvement of survival with response to neoadjuvant radiation therapy for rectal cancer. Arch Surg (2009) 0.79
Survival and quality of life after organ transplantation in veterans and nonveterans. Am J Surg (2003) 0.79
Refining a health-related quality of life assessment strategy for solid organ transplant patients. Clin Transplant (2004) 0.79
Health literacy of living kidney donors and kidney transplant recipients. Transplantation (2014) 0.79